Year |
Citation |
Score |
2019 |
Foote KM, Lyman KA, Han Y, Michailidis IE, Heuermann RJ, Mandikian D, Trimmer JS, Swanson GT, Chetkovich DM. Phosphorylation of the HCN channel auxiliary subunit TRIP8b is altered in an animal model of temporal lobe epilepsy and modulates channel function. The Journal of Biological Chemistry. PMID 31492750 DOI: 10.1074/Jbc.Ra119.010027 |
0.674 |
|
2018 |
Mandikian D, Figueroa I, Oldendorp A, Rafidi H, Ulufatu S, Schweiger MG, Couch JA, Dybdal N, Joseph SB, Prabhu S, Ferl GZ, Boswell CA. Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology. The Aaps Journal. 20: 107. PMID 30298434 DOI: 10.1208/S12248-018-0264-Z |
0.589 |
|
2018 |
Bishop HI, Cobb MM, Kirmiz M, Parajuli LK, Mandikian D, Philp AM, Melnik M, Kuja-Panula J, Rauvala H, Shigemoto R, Murray KD, Trimmer JS. Kv2 Ion Channels Determine the Expression and Localization of the Associated AMIGO-1 Cell Adhesion Molecule in Adult Brain Neurons. Frontiers in Molecular Neuroscience. 11: 1. PMID 29403353 DOI: 10.3389/Fnmol.2018.00001 |
0.692 |
|
2018 |
Mandikian D, Takahashi N, Lo AA, Li J, Eastham-Anderson J, Slaga D, Ho J, Hristopoulos M, Clark R, Totpal K, Lin K, Joseph SB, Dennis MS, Prabhu S, Junttila TT, et al. Relative Target Affinities of T Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model. Molecular Cancer Therapeutics. PMID 29339550 DOI: 10.1158/1535-7163.Mct-17-0657 |
0.579 |
|
2014 |
Mandikian D, Bocksteins E, Parajuli LK, Bishop HI, Cerda O, Shigemoto R, Trimmer JS. Cell type-specific spatial and functional coupling between mammalian brain Kv2.1 K+ channels and ryanodine receptors. The Journal of Comparative Neurology. 522: 3555-74. PMID 24962901 DOI: 10.1002/Cne.23641 |
0.624 |
|
2014 |
Speca DJ, Ogata G, Mandikian D, Bishop HI, Wiler SW, Eum K, Wenzel HJ, Doisy ET, Matt L, Campi KL, Golub MS, Nerbonne JM, Hell JW, Trainor BC, Sack JT, et al. Deletion of the Kv2.1 delayed rectifier potassium channel leads to neuronal and behavioral hyperexcitability. Genes, Brain, and Behavior. 13: 394-408. PMID 24494598 DOI: 10.1111/Gbb.12120 |
0.684 |
|
2011 |
Mandikian D, Cerda O, Sack JT, Trimmer JS. A SUMO-Phospho tag team for wrestling with potassium channel gating. The Journal of General Physiology. 137: 435-9. PMID 21518832 DOI: 10.1085/Jgp.201110648 |
0.699 |
|
Low-probability matches (unlikely to be authored by this person) |
2008 |
Schmidt M, Voutetakis A, Afione S, Zheng C, Mandikian D, Chiorini JA. Adeno-Associated Virus Type 12 (AAV12): a Novel AAV Serotype with Sialic Acid- and Heparan Sulfate Proteoglycan-Independent Transduction Activity Journal of Virology. 82: 1399-1406. PMID 18045941 DOI: 10.1128/Jvi.02012-07 |
0.245 |
|
2018 |
Dominguez SL, Hegde GV, Hanson JE, Xiang H, Mandikian D, Boswell CA, Chiu C, Wu Y, Tsai SP, Fleck D, Weber M, Ngu H, Scearce-Levie K, Jackson EL. Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice. Scientific Reports. 8: 8239. PMID 29844389 DOI: 10.1038/s41598-018-26492-4 |
0.241 |
|
2019 |
Lombana TN, Rajan S, Zorn JA, Mandikian D, Chen EC, Estevez A, Yip V, Bravo DD, Phung W, Farahi F, Viajar S, Lee S, Gill A, Sandoval W, Wang J, et al. Production, characterization, and half-life extension of polymeric IgA molecules in mice. Mabs. PMID 31122132 DOI: 10.1080/19420862.2019.1622940 |
0.178 |
|
2021 |
Junttila TT, Bravo-Perez D, Lo AA, Liang WC, Ziai J, Pham T, Ellerman D, Wu Y, Li J, Johnston J, Cai H, Ovacik M, Boswell CA, Mandikian D, Totpal K, et al. Anti-LYPD1/CD3 T cell dependent bispecific antibody for the treatment of ovarian cancer. Molecular Cancer Therapeutics. PMID 33536191 DOI: 10.1158/1535-7163.MCT-20-0490 |
0.154 |
|
2021 |
Ramos MK, Mandikian D, Sermeño LN, King A, Dent AT, Ho J, Ulufatu S, Lombana TN, Spiess C, Go MAT, Yu SF, Kamath AV, Ferl GZ, Boswell CA. Valency of HER2 targeting antibodies influences tumor cell internalization and penetration. Molecular Cancer Therapeutics. PMID 34253591 DOI: 10.1158/1535-7163.MCT-20-1097 |
0.141 |
|
2018 |
Mandikian D, Rafidi H, Adhikari P, Venkatraman P, Nazarova L, Fung G, Figueroa I, Ferl GZ, Ulufatu S, Ho J, McCaughey C, Lau J, Yu SF, Prabhu S, Sadowsky J, et al. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging. Mabs. PMID 30199303 DOI: 10.1080/19420862.2018.1521132 |
0.123 |
|
2020 |
Nazarova L, Rafidi H, Mandikian D, Ferl GZ, Koerber JT, Davies CW, Ulufatu S, Ho J, Lau J, Yu SF, Ernst J, Sadowsky JD, Boswell CA. Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-Length Antibodies. Molecular Cancer Therapeutics. PMID 32024685 DOI: 10.1158/1535-7163.Mct-19-1015 |
0.117 |
|
2017 |
Rajan S, Mandikian D, Baruch A, Gelzleichter TR, Stevens D, Sonoda J, Cowan K, Boswell CA, Stefanich E. Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals. Mabs. 0. PMID 28895785 DOI: 10.1080/19420862.2017.1373923 |
0.113 |
|
2021 |
Rafidi H, Estevez A, Ferl GZ, Mandikian D, Stainton S, Sermeno L, Williams SP, Kamath AV, Koerber JT, Boswell CA. Imaging reveals importance of shape and flexibility for glomerular filtration of biologics. Molecular Cancer Therapeutics. PMID 34315765 DOI: 10.1158/1535-7163.MCT-21-0116 |
0.097 |
|
2021 |
Dela Cruz Chuh J, Go M, Chen Y, Guo J, Rafidi H, Mandikian D, Sun Y, Lin Z, Schneider K, Zhang P, Vij R, Sharpnack D, Chan P, de la Cruz C, Sadowsky J, et al. Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response. Mabs. 13: 1862452. PMID 33382956 DOI: 10.1080/19420862.2020.1862452 |
0.09 |
|
2019 |
Famili A, Crowell S, Loyet KM, Mandikian D, Boswell CA, Cain D, Chan J, Comps-Agrar L, Kamath A, Rajagopal K. Hyaluronic Acid-Antibody Fragment Bioconjugates for Extended Ocular Pharmacokinetics. Bioconjugate Chemistry. PMID 31553572 DOI: 10.1021/Acs.Bioconjchem.9B00475 |
0.088 |
|
Hide low-probability matches. |